Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease

Digestive Diseases and Sciences

Volumn 47, Issue 11, 2002, Pages 2574-2578

  Johanson, John F ^a   Siddique, Reshmi ^b   Damiano, Anne M ^c   Jokubaitis, Leonard ^b   Murthy, Anita ^d   Bhattacharjya, Ashoke ^b  

^a Rockford Gastroenterology Associates   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c Health Economics and Outcomes Research   (United States)

^d EISAI INC   (United States)

Author keywords

Gastroesophageal reflux disease; Proton pump inhibitors; Quality of life; Rabeprazole; SF 36 Health Survey

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; RABEPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL STATUS; UNITED STATES; WELLBEING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BENZIMIDAZOLES; ENZYME INHIBITORS; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; QUALITY OF LIFE;

EID: 0036845697     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020532714664     Document Type: Article

References (13)

1. Revicki DA, Wood M, Maton PN, Sorensen S: The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104:252-258, 1998
2. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, Lundel L, Pedersen SA, Carlsson R, Junghard O, Stubberod A, Anker-Hansen O: Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole. Am J Gastroenterol 94:1782-1789, 1999
3. Kaplan-Machlis B, Spiegler GE, Revicki DA: Health-related quality of life in primary care patients with gastroesophageal reflux disease. Ann Pharmacother 33:1032-1036, 1999
4. Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, Revicki D: The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 161:45-52, 2001
5. Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO: Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 13:1621-1630, 1999
6. Cloud ML, Enas N, Humphries TJ, Bassion S. The Rabeprazole Study Group: Rabeprazole in treatment of acid peptic diseases: Results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). Dig Dis Sci 43:993-1000, 1998
7. Johnson D, Perdomo C, Barth J, Jokubaitis L: The benefit/risk profile of rabeprazole, a new proton-pump inhibitor. Eur J Gastroenterol Hepatol 2:799-806, 2000
8. Robinson M, Fitzgerald A, Hegedus R, Murthy A, Jokubaitis L: Onset of symptom relief with rabeprazole: A community-based open-label assessment of patients with erosive esophagitis. Aliment Pharmacol Ther 16:445-454, 2002
9. Ware JE, Snow KK, Kosinski M: SF-36 Health Survey Manual and Interpretation Guide. Boston. The Health Institute, New England Medical Center, 1993
10. Ware JE, Kosinski M, Keller SD: SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston. The Health Institute. New England Medical Center, 1994
11. Chal KL, Stacey JH, Sacks GE: The effect of ranitidine on symptom relief and quality of life of patients with gastro-oesophageal reflux disease. Br J Clin Pract 49:73-77, 1995
12. Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, Sabesin SM, Nicholas TA: Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: A clinical experience network (CEN) study. J Fam Pract 41:126-136, 1995
13. Mathias SD, Castell DO, Elkin EP, Matosian ML: Health-related quality of life of patients with acute erosive reflux esophagitis. Dig Dis Sci 41:2123-2129, 1996